1 ptomycetes proteins, the fungal protein is a surface active agent.

2                       Lung surfactant is the surface-active agent comprised of phospholipids and prot

3                                              Surface active agents derived from the non-toxic sweeten

4                     Two-dimensional films of surface-active agents-from phospholipids and proteins to

5                                    Auxiliary surface-active agents have been harnessed to stabilize t

6      Therapeutic administration of non-ionic surface-active agents is known to facilitate early colla

7 hat modification of tooth permselectivity by surface-active agents may be a viable method of decreasi

8 erved when KSL was used in the presence of a surface-active agent, or after biofilms were mechanicall

9 t of a nontoxic, nonionic block co-polymeric surface active agent, poloxamer 188, on electroporation

10 points the potential contribution from other surface-active agents such as surface/ secreted proteins

11 microemulsions, and microfoams stabilised by surface-active agents such as surfactants and colloidal

12                                              Surface active agents (surfactants) have found a variety